FRCPath2Macro_Feb 2012 Final

download FRCPath2Macro_Feb 2012 Final

of 43

Transcript of FRCPath2Macro_Feb 2012 Final

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    1/43

    The FRCPath SurgicalPathology Module

    macroscopic specimens

    Helen Baker

    Consultant Histopathologist

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    2/43

    CASE 1. BreastKey - Wide local excision for mammography screening detected breastlump.Specimen sliced from medial to lateral aspects.Yellow paint - superiorBlue paint - anteriorRed paint - inferior

    1) Indicate on the diagram the blocks you would take from thisspecimen.2) What other information would you record before and during specimendissection?3) How would you modify your specimen dissection for a wide local

    excision if a tumour mass was not visible and for DCIS?4) How would you deal with:

    a) cavity shaves ?b) sentinel lymph nodes ?

    5) What additional blocks would you take in a mastectomy case and givetheir rationale?

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    3/43

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    4/43

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    5/43

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    6/43

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    7/43

    CASE 1. Breast

    1) Indicate on the diagram the blocks you would takefrom this specimen.

    Tumour and involved / nearest margins. Adjacent fibrotictissue. Anterior and posterior to the tumour/DCIS inlarger WLEs to assess extent of DCIS, which canbe more than measured radiologically,macroscopically. Spreads in this plane, along ducts.Any unusual areas and associated margins.

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    8/43

    Case 1

    2) What other information would you record before and duringspecimen dissection?

    Accompanying X- Ray present or absent. If lesion is

    visible in WLE, describe the lesion. Presence of guide-wireand its relation to the lesion.

    Weight of specimen, measurement of specimen in threedimensions. Measurement of tumour in three dimensionsand distance to margins. Record abnormal lesions and

    relations to margins. Block code essential, +/- diagram.

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    9/43

    Case 1

    3) What additional blocks would you take in a mastectomycase and give their rationale

    Tumour to give dimensions and relevant margins

    Nipple -areolar complex Paget'sAdjacent / ant and post to tumour for accurate sizing

    Any abnormal area and margins

    Random quadrantic blocks background breast / occultextensive disease

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    10/43

    Case 14) How would you deal with:a) cavity shaves ?

    b) sentinel lymph nodes ?

    Cavity shave measure, paint , orientate with different colours if

    orientated by surgeon. Serially slice, all embed.Sentinel node radioactive time lapse before dissection.

    Measure , record if blue, record size of entire tissue and nodesize, serially slice node at 2mm intervals , CAM5.2 or equivalent

    marker, levels. Report H& E and immunos in conjunction.

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    11/43

    Common Errors by Candidates

    No mention of X-ray

    cavity shave limited to block it all

    mastectomy: no mention of backgroundbreast; no mention of axillary tail or lymphnodes

    cruciate means like a cross

    no block code

    gigantic blocks; indiscriminate blocks

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    12/43

    CASE 2. Prostate

    1) Indicate on the photograph the blocks you would take from thisspecimen

    2) What other information would you record prior to and duringspecimen dissection ?

    3) How would you deal with accompanying lymphadenectomyspecimens ?

    4) What characteristics of the tumour would you reporthistologically ?

    5) What immunohistochemical stains may help you in reportingprostatectomy specimens ?

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    13/43

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    14/43

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    15/43

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    16/43

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    17/43

    CASE 2. Prostate

    1) Indicate on the photograph the blocks you would take from thisspecimen

    2) What other information would you record prior to and duringspecimen dissection ?

    3) How would you deal with accompanying lymphadenectomyspecimens ?

    4) What characteristics of the tumour would you reporthistologically ?

    5) What immunohistochemical stains may help you in reportingprostatectomy specimens ?

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    18/43

    Case 2 - Answers

    Vas margins, apex and base margins, seminal vesicles, slice at 3-5mm intervals, whole mount or extensive sampling of CRM

    Weight , size, visible tumour location and size, number of slices,photographs if facilities available. Block code.

    Identify and separate nodes. Rest of fat to be processed

    Type, differentiation, grade, perineural and vascular invasion,location ant, post, central, lateral, multifocal, zones, % glandinvolvement / volume of tumour, breach of margins, extension intofat, seminal vesicles, involve of apical and base blocks, otherorgans

    PSA, PSAP confirming prostatic origin. 34BetaE12 or CK5/6 distinguishing invasive from in situ disease. AMACR increasedexpression in cancer and in situ disease. Combined immunos.

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    19/43

    Common Errors by Candidates

    block code

    gigantic blocks; indiscriminate blocks

    other information: no description of visibletumour

    not processing fat for lymph nodes

    lots of things left out of Minimum Data Set:why block it if youre not going to write aboutit?

    immunos: not mentioning prostatic markers

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    20/43

    Case 3

    Soft Tissue -

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    21/43

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    22/43

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    23/43

    Case 3 Soft Tissue

    What information would you include in your report ?

    Macroscopy

    Specimen weighed and measured in three dimensions

    Plane of section in which tumour located should be recorded

    Measurements of tumour to nearest margins, including anteriorand posterior

    Dimensions of tumour

    Tumour characteristics cystic areas, solid areas,haemorrhage, necrosis assess percentage, different colours,consistencies.

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    24/43

    Case 3 Soft Tissue

    Blocks 1 per cm, at leastBlocks from each different area of consistencyBlocks to include nearest marginsSpecimen less than 50mm m.d. all embedHigh grade lesions diagnosed on biopsy may need fewerblocksDedifferentiated liposarcoma, esp. undifferentiated

    pleomorphic sarcomas or myxofibrosarcomas innocuousfatty tissue at edge of lesion sampled thoroughly for welldifferentiated liposarcoma areas

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    25/43

    Case 3 Soft Tissue

    Minimal info in report:

    1 - Size of tumour

    2 - Histological type

    3 - Grade, FNCLCC;

    4 - Tissue planes involved

    5 - Tumour invasive edge; pushing/infiltrative

    6 - Margins: Distance to the nearest margin

    Tissue forming margin e.g. muscle, fascia

    7 - Vascular invasion

    8 - Genetic findings

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    26/43

    Case 3 Soft Tissue

    What advice would you give to clinicians and thelaboratory after removal of resection specimens and corebiopsies ?

    Clinicians Biopsies - Fix in formalin promptly

    Some tissue can be separated and frozen in liquid nitrogen -genetic studies.

    Encourage clinicians to send resections promptly - fresh sampled for genetic studies, better histology

    Easier to orientate before fixation

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    27/43

    Case 3 Soft Tissue

    Surgeons should be encouraged to orientate specimens in astandard fashion agreed between both the surgeon and thepathologist, and provide diagrams in particularly complexcases.

    Laboratory

    Promptly inform pathologist of arrival of specimen, so freshtissue can be taken for cytogenetics and the tissue can bepainted and sliced promptly for optimum tissue fixation.

    Shallow H&E sections initially with biopsies to preserve tissuewhich may be required for immunohistochemistry and ancillarytests.

    Fatty tissue may require extra fixation before processing.

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    28/43

    Case 3 Soft Tissue

    What system of grading is used for sarcomas and whathistological parameters are measured ?

    French Federation of Cancer Centers System of Grading

    Tumour differentiation

    Score 1 Sarcoma histologically very similar to normal adultmesenchymal tissue

    2 Sarcoma of defined histological subtype (e.g.myxofibrosarcoma)

    3 Sarcoma of uncertain type, embryonal and undifferentiatedsarcomas

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    29/43

    Case 3 Soft Tissue

    Mitosis countScore 1 09 10 HPF2 1019 10 HPF3 >20 10 HPF

    Microscopic tumour necrosisScore 0 - No necrosis1 < 50% tumour necrosis2 > 50% tumour necrosis

    Histological gradeGrade 1 Total score 2 or 3Grade 2 Total score 4 or 5Grade 3 Total score 6, 7 or 8

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    30/43

    Common Errors

    no vascular invasion

    no tissue planes involved

    no margins: pushing/infiltrative no type of differentiation

    no information about standard gradingsystem

    funny sized blocks

    no sampling of different areas

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    31/43

    Case 4 Colon

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    32/43

    Briefly note the macroscopic and microscopic featuresyou would record

    Macroscopy

    Type of resection

    Mucosal abnormalities and distribution of disease process proximal, distal, continuous, patchy

    Full thickness of wall involved ?

    Fat wrapping

    Serosal abnormalities

    Adhesions/ attached organs

    Case 4 Colon

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    33/43

    Macroscopy

    Strictures

    Tumours

    Polyps/ raised areas

    Perforations Prominent nodes

    Tissue sampling

    Proximal and distal resection margins Mapped samples of bowel at regular (at least10cm) intervals

    Note if abnormal or normal mucosa

    Interfaces between diseased and non diseased areas

    Case 4 Colon

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    34/43

    Tissue sampling

    Polyps

    Raised areas and sampled flat mucosa around them

    Strictures

    Tumours

    Serosal abnormalities

    Attached organs

    Sample lymph nodes

    Case 4 Colon

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    35/43

    Microscopy Active inflammation

    LP cellularity

    Crypt irregularities

    Mucin depletion

    Pattern of inflammation mucosal, transmural ulceration deep fissuring, shallow, perforation

    patchy, continuous

    granulomata

    Fibrosis

    Dysplasia/ tumours inc staging. DALMs

    Margin involvement/ viability

    Supervening infections i.e. CMV

    Nodes reactive, granulomata

    Case 4 Colon

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    36/43

    What disease entities would you be considering with thismacroscopic picture and what clinical information wouldbe optimal before reporting the specimen ?

    Idiopathic inflammatory bowel disease Crohn's disease

    Ulcerative colitis

    Indeterminate colitis

    Pseudomembranous / infective

    Ischaemia

    Demographics

    Imaging

    Case 4 Colon

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    37/43

    What disease entities would you be considering with thismacroscopic picture and what clinical information wouldbe optimal before reporting the specimen ?

    Involved bowel segments Fistulae/ cutaneous manifestations

    Other associated diseases

    Topical treatment

    Arteriopath ?

    Recent antibiotics

    Foreign travel

    Case 4 Colon

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    38/43

    In the presence of dysplasia, what other histologicalinformation should be given ?

    Grade Low or high

    Sporadic adenoma type flat, tva, va, serrated. DALM need tissue from around to distinguish

    Extent of dysplasia

    Associated invasive disease

    Margins

    Case 4 Colon

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    39/43

    Common Errors

    no mention of fat wrapping or of skiplesions

    Topography no lymph node or appendix block

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    40/43

    Macro Score Summary

    15 candidates submitted their macros

    13 Pass mark

    1 B/L 1 Fail

    Overall you did very well!

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    41/43

    Summary

    Sections that were well answered: Breast , Prostate + Colon generally answered well.

    Sections candidates struggled on:

    Soft Tissue case was less well done.

    Candidates only answering about Microscopy findings on report + notmentioning Macroscopy.

    Summary of common mistakes:

    Not using X-rays in DCIS.

    Not mentioning vascular invasion. Not mentioning use of immuno in sentinel node protocol.

    Lots of people forgot to say they would document color code andblock key on breast + prostate cases.

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    42/43

    Final advice for candidates

    Read the question in full and answereach point.

    Explanatory notes next to blocks aboutgeneral approach or significance of

    taking a specific block helps examinergain an understanding of yourapproach.

  • 8/2/2019 FRCPath2Macro_Feb 2012 Final

    43/43

    The End